Senner Christopher J.
Exelixis Inc · EVP and CFO
Senner Christopher J. is listed in public filings as officer: EVP and CFO. This Senner Christopher J. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Exelixis Inc (EXEL), and Quince Therapeutics, Inc. (QNCX). Investors use Senner Christopher J.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $48M952.3k shares | SellMay 18, 2026 | $1.7M34.9k shares | $50.00 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $50M987.2k shares | Grant / ExerciseMay 15, 2026 | $2.1M40.9k shares | $51.10 | -- | |
| --1M shares | Grant / ExerciseFeb 26, 2026 | Disclosure amount unavailable52k shares | -- | -- | |
| $43M976.1k shares | SellFeb 17, 2026 | $1.3M30.6k shares | $43.67 | -- | |
| $44M1M shares | Grant / ExerciseFeb 15, 2026 | $1.6M35.9k shares | $43.92 | -- | |
| $45M1M shares | SellFeb 13, 2026 | $1.5M34.3k shares | $43.00 | -- | |
| $49M1.1M shares | Grant / ExerciseJan 15, 2026 | $1.8M40.5k shares | $45.23 | -- | |
| --1.1M shares | Grant / ExerciseJan 15, 2026 | Disclosure amount unavailable149.5k shares | -- | -- | |
| $65k21.8k shares | Grant / ExerciseJan 2, 2026 | $65.4K21.8k shares | $3.00 | -- | |
| $29k27k shares | Grant / ExerciseJun 4, 2025 | $29.4K27k shares | $1.09 | -- | |
| $45M967.8k shares | SellMay 16, 2025 | $4.6M100k shares | $46.00 | -- | |
| $0100k shares | Grant / ExerciseMay 16, 2025 | $1.9M100k shares | $18.80 | -- | |
| $43M967.8k shares | Grant / ExerciseMay 15, 2025 | $1.8M41.4k shares | $44.65 | -- | |
| --1M shares | Grant / ExerciseMar 31, 2025 | Disclosure amount unavailable170k shares | -- | -- | |
| --839.3k shares | Grant / ExerciseFeb 26, 2025 | Disclosure amount unavailable59.6k shares | -- | -- | |
| $28M779.6k shares | SellFeb 24, 2025 | $1.1M29.3k shares | $36.14 | -- | |
| $1.9M100k shares | Grant / ExerciseFeb 24, 2025 | $551.1K29.3k shares | $18.80 | -- | |
| $27M779.6k shares | Grant / ExerciseFeb 15, 2025 | $755.7K21.6k shares | $35.00 | -- | |
| $30M801.2k shares | Grant / ExerciseJan 16, 2025 | $1.3M35.9k shares | $37.27 | -- | |
| --837.1k shares | Grant / ExerciseJan 16, 2025 | Disclosure amount unavailable133k shares | -- | -- | |
| $66k35.3k shares | Grant / ExerciseJan 2, 2025 | $66.3K35.3k shares | $1.88 | -- | |
| $25M704.2k shares | Grant / ExerciseNov 15, 2024 | $613.6K17.5k shares | $35.05 | -- | |
| $20M721.7k shares | SellAug 9, 2024 | $3.4M125k shares | $27.19 | -- | |
| $0125k shares | Grant / ExerciseAug 9, 2024 | $3.1M125k shares | $24.41 | -- |